2022
DOI: 10.1101/2022.03.01.482558
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

ECD of PepT1 interacts with TM1 to facilitate substrate transport

Abstract: Mammalian peptide transporters, PepT1 and PepT2, mediate uptake of a wide variety of di- and tri-peptides and are essential for the absorption of dietary peptides in the digestive tract and the recovery of peptides in renal filtrate. PepT also mediates absorption of many drugs and prodrugs to enhance their bioavailability. PepT has 12 transmembrane (TM) helices that fold into two domains, the N-terminal domain (NTD, TM1-6) and C-terminal domain (CTD, TM7-12), and a large extracellular domain (ECD) of ~200 amin… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…In the last decade, over 50 entries of the POT family were deposited in the Protein Data Bank (PDB), representing eleven bacterial and two mammalian homologs, bound to eight unique natural di-and tripeptides (Ala-Phe, Ala-Glu, Ala-Gln, Ala-Leu, Phe-Ala, Phe-Ala-Gln, Ala-Ala-Ala, alafosfalin), peptidomimetic drugs (valaciclovir, valganciclovir, 5-aminolevulinic acid) and a potent transport inhibitor Lys[Z(NO2)]-Val [3][4][5][6][7][8]10,18,[31][32][33][34][35][36][37][38][39][40][41] . These efforts revealed the basic principle underlying peptide binding in POTs which can be described as an electrostatic clamping mechanism between the invariable part of peptides (N-and C-termini as well as the peptide backbone) and conserved residues in the transporter (mainly via arginine, lysine, glutamate, asparagine and tyrosine residues).…”
Section: Introductionmentioning
confidence: 99%
“…In the last decade, over 50 entries of the POT family were deposited in the Protein Data Bank (PDB), representing eleven bacterial and two mammalian homologs, bound to eight unique natural di-and tripeptides (Ala-Phe, Ala-Glu, Ala-Gln, Ala-Leu, Phe-Ala, Phe-Ala-Gln, Ala-Ala-Ala, alafosfalin), peptidomimetic drugs (valaciclovir, valganciclovir, 5-aminolevulinic acid) and a potent transport inhibitor Lys[Z(NO2)]-Val [3][4][5][6][7][8]10,18,[31][32][33][34][35][36][37][38][39][40][41] . These efforts revealed the basic principle underlying peptide binding in POTs which can be described as an electrostatic clamping mechanism between the invariable part of peptides (N-and C-termini as well as the peptide backbone) and conserved residues in the transporter (mainly via arginine, lysine, glutamate, asparagine and tyrosine residues).…”
Section: Introductionmentioning
confidence: 99%
“…Members of the SLC15 family of proton-coupled oligopeptide transporters (POTs), namely SLC15A3 (PHT2) and SLC15A4 (PHT1), are localized to the lysosomal membrane. These two lysosomal SLC15 members share structural similarities with their plasma membrane-localized relatives, SLC15A1 (PepT1) and SLC15A2 (PepT2), and bacterial POT members that have been extensively characterized on a structural and functional level (Custodio et al, 2023;Killer et al, 2021;Kotov et al, 2023;Newstead, 2017;Parker et al, 2021;Shen et al, 2022). Overall, they all share the major facilitator superfamily (MFS) fold as well as typical POT signature motifs that are implicated in proton-coupling and peptide translocation (Aduri et al, 2015;Doki et al, 2013;Jensen et al, 2012;Parker et al, 2017;Solcan et al, 2012).…”
Section: Introductionmentioning
confidence: 99%